Akebia Therapeutics Inc (NASDAQ: AKBA) Stock In Prove Me State

Akebia Therapeutics Inc (AKBA) concluded trading on Thursday at a closing price of $3.01, with 7.55 million shares of worth about $22.71 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 60.11% during that period and on May 29, 2025 the price saw a […]

Akebia Therapeutics Inc (NASDAQ: AKBA) – Suitable For Long Term Buy?

Currently, there are 261.64M common shares owned by the public and among those 251.86M shares have been available to trade. The company’s stock has a 5-day price change of 15.23% and 35.27% over the past three months. AKBA shares are trading 47.37% year to date (YTD), with the 12-month market performance up to 137.29% higher. […]

Investors Should Take Note Of Akebia Therapeutics Inc (AKBA)

Akebia Therapeutics Inc (AKBA) concluded trading on Thursday at a closing price of $2.54, with 3.59 million shares of worth about $9.13 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 27.64% during that period and on May 15, 2025 the price saw a […]

Analysts Update Their Price Forecasts For Akebia Therapeutics Inc (AKBA)

Akebia Therapeutics Inc (AKBA) concluded trading on Thursday at a closing price of $2.62, with 10.58 million shares of worth about $27.73 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 41.62% during that period and on May 08, 2025 the price saw a […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.